Suxin Li

1.9k total citations · 3 hit papers
42 papers, 1.4k citations indexed

About

Suxin Li is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Suxin Li has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Biomedical Engineering. Recurrent topics in Suxin Li's work include interferon and immune responses (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Suxin Li is often cited by papers focused on interferon and immune responses (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Suxin Li collaborates with scholars based in China, United States and France. Suxin Li's co-authors include Jinming Gao, Baran D. Sumer, Jian Wang, Jonathan Wilhelm, Xueqing Wang, Wenbing Dai, Bing He, Binlong Chen, Qiang Feng and Hua Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Accounts of Chemical Research.

In The Last Decade

Suxin Li

39 papers receiving 1.4k citations

Hit Papers

Lactate increases stemness of CD8 + T cells to augment an... 2021 2026 2022 2024 2022 2021 2024 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
    2022 254 citations Qiang Feng, Zhida Liu et al. Nature Communications profile →
  2. Prolonged activation of innate immune pathways by a polyvalent STING agonist
    2021 240 citations Suxin Li, Min Luo et al. Nature Biomedical Engineering profile →
  3. STING licensing of type I dendritic cells potentiates antitumor immunity
    2024 63 citations Suxin Li, Xu Wang et al. Science Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suxin Li China 15 619 534 435 284 237 42 1.4k
Xiaojuan Wang China 19 806 1.3× 454 0.9× 275 0.6× 114 0.4× 222 0.9× 46 1.9k
João Conniot Portugal 15 697 1.1× 425 0.8× 588 1.4× 451 1.6× 216 0.9× 19 1.6k
Henrique Faneca Portugal 26 1.4k 2.2× 180 0.3× 399 0.9× 437 1.5× 211 0.9× 57 2.1k
Zhijin Fan China 21 621 1.0× 199 0.4× 604 1.4× 169 0.6× 89 0.4× 47 1.2k
Yujie Shi China 23 799 1.3× 218 0.4× 347 0.8× 226 0.8× 220 0.9× 66 1.7k
Partha Pratim Manna India 25 429 0.7× 514 1.0× 383 0.9× 191 0.7× 278 1.2× 92 1.8k
Brandon Piel United States 8 472 0.8× 336 0.6× 415 1.0× 409 1.4× 287 1.2× 10 1.2k
Heather H. Gustafson United States 10 896 1.4× 665 1.2× 565 1.3× 554 2.0× 322 1.4× 14 2.1k
Luo‐Qin Fu China 14 403 0.7× 229 0.4× 235 0.5× 123 0.4× 184 0.8× 31 1.0k
Weifen Zhang China 19 403 0.7× 152 0.3× 277 0.6× 192 0.7× 88 0.4× 41 1.1k

Countries citing papers authored by Suxin Li

Since Specialization
Citations

This map shows the geographic impact of Suxin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxin Li more than expected).

Fields of papers citing papers by Suxin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suxin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxin Li. The network helps show where Suxin Li may publish in the future.

Co-authorship network of co-authors of Suxin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Suxin Li. A scholar is included among the top collaborators of Suxin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suxin Li. Suxin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Suxin, et al.. (2025). circ_0046599 Promotes HCC Progression by Competing with miR-1322 to Enhance NT5DC2 Expression. Journal of Cancer. 16(7). 2275–2288.
2.
Su, Xiaodan, et al.. (2025). Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy. ACS Nano. 19(29). 26296–26319. 1 indexed citations
3.
4.
Li, Shixuan, Shuting Xiang, Mingxi Li, et al.. (2025). Metallic nanomedicine in cancer immunotherapy. Acta Pharmaceutica Sinica B. 15(9). 4614–4643. 3 indexed citations
5.
Li, Suxin, Xu Wang, Shuqing Chen, et al.. (2024). STING licensing of type I dendritic cells potentiates antitumor immunity. Science Immunology. 9(92). eadj3945–eadj3945. 63 indexed citations breakdown →
6.
Li, Suxin, Jia Song, Xian‐Fu Zheng, et al.. (2024). 3,4-Dichlorophenylacetic acid acts as an auxin analog and induces beneficial effects in various crops. Communications Biology. 7(1). 161–161. 2 indexed citations
7.
Yan, Kun, et al.. (2023). Salt adaptability of wolfberry (Lycium chinense) in terms of photosystems performance and interaction. Scientia Horticulturae. 321. 112317–112317. 4 indexed citations
8.
9.
Feng, Qiang, Zhida Liu, Xuexin Yu, et al.. (2022). Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nature Communications. 13(1). 4981–4981. 254 indexed citations breakdown →
10.
Li, Suxin, et al.. (2022). Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma. Frontiers in Immunology. 13. 1076045–1076045. 14 indexed citations
11.
Li, Suxin, Min Luo, Zhaohui Wang, et al.. (2021). Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering. 5(5). 455–466. 240 indexed citations breakdown →
12.
Li, Suxin, Min Luo, Zhaohui Wang, et al.. (2021). Author Correction: Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering. 5(5). 483–483. 5 indexed citations
13.
Li, Suxin, Yanbin Tong, Hongyu Dong, Jianjiang Lu, & Junfeng Niu. (2021). Formation of stable imine intermediates in the coexistence of sulfamethoxazole and humic acid by electrochemical oxidation. Journal of Hazardous Materials. 427. 128166–128166. 26 indexed citations
14.
Wang, Xu, Jonathan Wilhelm, Wei Li, et al.. (2020). Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window. Nature Communications. 11(1). 5828–5828. 79 indexed citations
15.
Li, Suxin, Na Huang, Xiaowei Dang, et al.. (2020). A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism. Viral Immunology. 33(2). 112–121. 1 indexed citations
16.
Liang, Yanqin, Suxin Li, Yuan Zhang, et al.. (2018). A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers. Journal of Controlled Release. 275. 129–141. 45 indexed citations
17.
Shi, Yujie, Zujin Shi, Suxin Li, et al.. (2017). The interactions of single-wall carbon nanohorns with polar epithelium. International Journal of Nanomedicine. Volume 12. 4177–4194. 13 indexed citations
18.
19.
Fan, Wenqiang, Mengyao Zhao, Suxin Li, et al.. (2016). Contrasting transcriptional responses of PYR1/PYL/RCAR ABA receptors to ABA or dehydration stress between maize seedling leaves and roots. BMC Plant Biology. 16(1). 73–73. 71 indexed citations
20.
Wang, Xueqing, Suxin Li, Yujie Shi, et al.. (2014). The development of site-specific drug delivery nanocarriers based on receptor mediation. Journal of Controlled Release. 193. 139–153. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojuan Wang Breakdown of academic impact, for papers by João Conniot Breakdown of academic impact, for papers by Henrique Faneca Breakdown of academic impact, for papers by Zhijin Fan Breakdown of academic impact, for papers by Yujie Shi Breakdown of academic impact, for papers by Partha Pratim Manna Breakdown of academic impact, for papers by Brandon Piel Breakdown of academic impact, for papers by Heather H. Gustafson Breakdown of academic impact, for papers by Luo‐Qin Fu Breakdown of academic impact, for papers by Weifen Zhang
Rankless by CCL
2026